VERMOX is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Johnson & Johnson Consumer Inc, Mcneil Consumer Healthcare Division. The primary component is Mebendazole.
| Product ID | 50580-070_3e39b5e3-d0de-4d0d-93a5-071198551c0e |
| NDC | 50580-070 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERMOX |
| Generic Name | Mebendazole |
| Dosage Form | Tablet, Chewable |
| Route of Administration | ORAL |
| Marketing Start Date | 1975-01-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017481 |
| Labeler Name | Johnson & Johnson Consumer Inc, McNeil Consumer Healthcare Division |
| Substance Name | MEBENDAZOLE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Anthelmintic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1975-01-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017481 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1975-01-14 |
| Ingredient | Strength |
|---|---|
| MEBENDAZOLE | 100 mg/1 |
| SPL SET ID: | f57dac6d-60bd-4230-ae10-d2b71a91b37f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-675 | VERMOX | mebendazole |
| 50580-070 | VERMOX | mebendazole |
| 64896-669 | Emverm | mebendazole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VERMOX 86870940 not registered Live/Pending |
Johnson & Johnson 2016-01-11 |
![]() VERMOX 86065978 not registered Live/Pending |
Zylera Pharmaceuticals LLC 2013-09-16 |
![]() VERMOX 85833992 not registered Dead/Abandoned |
JOHNSON & JOHNSON 2013-01-28 |
![]() VERMOX 73362222 1261438 Dead/Cancelled |
Johnson & Johnson 1982-04-29 |